title: Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.
abstract: The transcription factor CCAAT enhancer binding protein α (C/EBPα) is a master regulator in granulopoiesis and is frequently disrupted in acute myeloid leukemia (AML). We have previously shown that C/EBPα exerts its effects by regulating microRNAs (miRs) such as miR-223 and miR-34a. Here, we confirm miR-30c as a novel important target of C/EBPα during granulopoiesis. Thus, wild-type C/EBPα-p42 directly upregulates miR-30c expression, whereas C/EBPα-p30, found in AML, does not. miR-30c is downregulated in AML, especially in normal karyotype AML patients with CEBPA mutations. An induced C/EBPα knockout in mice leads to a significant downregulation of miR-30c expression in bone marrow cells. We identified NOTCH1 as a direct target of miR-30c. Finally, a block of miR-30c prevents C/EBPα-induced downregulation of Notch1 protein and leads to a reduced CD11b expression in myeloid differentiation. Our study presents the first evidence that C/EBPα, miR-30c, and Notch1 together play a critical role in granulocytic differentiation and AML, and particularly in AML with CEBPA mutations. These data reveal the importance of deregulated miRNA expression in leukemia and may provide novel biomarkers and therapeutic targets in AML.
authors: Division of Hematology and Oncology, Leipzig University Hospital, Leipzig, Germany;
authors: Christiane
authors: C
authors: Katzerke
authors: Vikas
authors: V
authors: Madan
authors: Dennis
authors: D
authors: Gerloff
authors: Daniela
authors: D
authors: Bräuer-Hartmann
authors: Jens-Uwe
authors: JU
authors: Hartmann
authors: Alexander Arthur
authors: AA
authors: Wurm
authors: Carsten
authors: C
authors: Müller-Tidow
authors: Susanne
authors: S
authors: Schnittger
authors: Daniel G
authors: DG
authors: Tenen
authors: Dietger
authors: D
authors: Niederwieser
authors: Gerhard
authors: G
authors: Behre
mesh_terms: D000818:Animals; D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000378:metabolism*; D002454:Cell Differentiation / Q000502:physiology; D047369:Chromatin Immunoprecipitation; D015536:Down-Regulation; D015972:Gene Expression Regulation, Neoplastic; D006098:Granulocytes / Q000166:cytology* / Q000378:metabolism; D006801:Humans; D015151:Immunoblotting; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000378:metabolism*; D019891:Leukopoiesis / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D060888:Real-Time Polymerase Chain Reaction; D051881:Receptor, Notch1 / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014162:Transfection
chemical_list: D022763:CCAAT-Enhancer-Binding Protein-alpha; D035683:MicroRNAs; D051881:Receptor, Notch1
references: J Clin Oncol. 2004 Feb 15;22(4):624-33
references: 14726504
references: Haematologica. 2011 Dec;96(12):1783-91
references: 21880628
references: Leukemia. 2010 May;24(5):914-23
references: 20376080
references: Nat Rev Cancer. 2003 Feb;3(2):89-101
references: 12563308
references: Mol Cell Biol. 1998 Jul;18(7):4301-14
references: 9632814
references: Nat Immunol. 2004 Mar;5(3):247-53
references: 14985712
references: Haematologica. 2008 Jul;93(7):1009-16
references: 18508790
references: Stem Cells. 1999;17(3):162-71
references: 10342559
references: Nat Rev Immunol. 2007 Feb;7(2):105-17
references: 17259967
references: Nat Genet. 2001 Mar;27(3):263-70
references: 11242107
references: Int J Hematol. 2010 May;91(4):557-68
references: 20422469
references: Breast Cancer Res Treat. 2011 May;127(1):43-51
references: 20490652
references: Cell. 2005 Dec 2;123(5):819-31
references: 16325577
references: Oncogene. 2010 Jul 22;29(29):4194-204
references: 20498642
references: Blood. 1998 Jun 1;91(11):4084-91
references: 9596653
references: Cancer Cell. 2008 Apr;13(4):299-310
references: 18394553
references: Blood. 2010 Dec 16;116(25):5638-49
references: 20889924
references: Blood. 2003 Nov 1;102(9):3163-71
references: 12869508
references: J Neurosci. 2009 Dec 2;29(48):15161-8
references: 19955368
references: Immunity. 2004 Dec;21(6):853-63
references: 15589173
references: Blood. 2010 Mar 4;115(9):1768-78
references: 20029046
references: Biochim Biophys Acta. 2006 Aug;1766(1):88-103
references: 16616425
references: Blood. 2002 Feb 15;99(4):1332-40
references: 11830484
references: Blood. 2010 Aug 26;116(8):1321-8
references: 20410507
references: J Clin Oncol. 2009 Feb 1;27(4):619-28
references: 19075268
references: Eur J Haematol. 2008 Oct;81(4):304-10
references: 18573170
references: Cancer Cell. 2006 Nov;10(5):401-11
references: 17097562
references: Immunity. 1998 Jan;8(1):43-55
references: 9462510
references: Nat Rev Immunol. 2008 May;8(5):380-90
references: 18421304
references: N Engl J Med. 2008 May 1;358(18):1919-28
references: 18450603
references: Blood. 2005 Nov 15;106(10):3618-20
references: 16046528
references: Blood. 2007 Nov 15;110(10):3706-14
references: 17671232
references: Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13014-9
references: 8917536
references: Leuk Lymphoma. 1997 Mar;25(1-2):37-46
references: 9130612
references: Int Urol Nephrol. 2010 Mar;42(1):95-102
references: 19475496
references: Curr Opin Hematol. 2008 Jul;15(4):352-8
references: 18536574
references: Oncol Rep. 2012 Mar;27(3):807-12
references: 22139444